Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Silico Peptide Design: Methods, Resources, and Role of AI.

Journal of peptide science : an official publication of the European Peptide Society·2025
Same author

In-silico prediction of coat protein structure of Indian citrus ringspot virus and their interactions with the Argonaut2/DCL4 proteins.

Virusdisease·2025
Same author

Identification of rheochrysin as a potential anti-cancer inhibitor of NAD(P) H quinone oxidoreductase 1 through ensemble virtual screening, molecular dynamics, MM-GBSA and DFT.

International journal of biological macromolecules·2025
Same author

In silico design of dehydrophenylalanine containing peptide activators of glucokinase using pharmacophore modelling, molecular dynamics and machine learning: implications in type 2 diabetes.

Journal of computer-aided molecular design·2024
Same author

Systematic Review and Meta-analysis Indicating Curcumin to Enhance the Synergistic Potential of Paclitaxel and Reduce Cell Viability, Tumor Volume, and Drug Resistance in Different Cancers.

Current medicinal chemistry·2024
Same author

Identification and characterization of the in-vivo metabolites of the novel soluble epoxide hydrolase inhibitor EC5026 using liquid chromatography quadrupole time of flight mass spectrometry.

Journal of pharmaceutical and biomedical analysis·2024

Related Experiment Video

Updated: Jul 4, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

Machine Learning, Molecular Docking, and Dynamics-Based Computational Identification of Potential Inhibitors against

Agneesh Pratim Das1,2, Puniti Mathur2, Subhash M Agarwal1

  • 1Bioinformatics Division, ICMR-National Institute of Cancer Prevention and Research, I-7, Sector-39, Noida 201301, Uttar Pradesh, India.

ACS Omega
|February 5, 2024
PubMed
Summary

Machine learning identified novel natural product inhibitors for lung cancer treatment. Indolocarbazole compounds showed significant potential, validated by molecular dynamics simulations, offering new therapeutic avenues.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.1K

Related Experiment Videos

Last Updated: Jul 4, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.1K

Area of Science:

  • Computational chemistry and pharmacology
  • Drug discovery and development
  • Machine learning in bioinformatics

Background:

  • Lung cancer remains a leading cause of cancer mortality globally.
  • Acquired resistance to existing therapies presents a major clinical challenge.
  • Phytomolecules offer diverse chemical structures for novel drug development.

Purpose of the Study:

  • To develop a machine learning model for identifying phytomolecule-based lung cancer inhibitors.
  • To screen a large natural product database for potential anti-lung cancer agents targeting EGFR mutants.
  • To validate promising natural product candidates using molecular docking and dynamics simulations.

Main Methods:

  • Development and comparison of four machine learning models (k-NN, RF, SVM, XGBoost) with MACCS and Morgan2 fingerprints.
  • Virtual screening of ~400,000 natural products from the COCONUT database using docking against EGFR mutants.
  • Molecular dynamics simulations and structural similarity analysis of top-ranked indolocarbazole compounds.

Main Results:

  • The random forest model with MACCS fingerprints demonstrated superior performance in predicting inhibitory activity.
  • A multistep screening identified 205 potential natural product inhibitors, with a notable enrichment of indolocarbazole scaffolds.
  • Top indolocarbazole molecules exhibited strong binding affinity and stability via molecular dynamics, showing similarity to known EGFR mutant inhibitors.

Conclusions:

  • Machine learning, molecular docking, and dynamics simulations effectively identified promising natural product inhibitors for lung cancer.
  • Indolocarbazole-based natural products represent a highly promising class of compounds for targeting lung cancer, particularly EGFR mutants.
  • This study highlights the potential of integrating computational approaches for accelerating the discovery of novel anti-cancer therapeutics.